A comprehensive update of the 2005 edition Examines the market for addiction pharmacotherapies currently estimated at US$2 billionThe substance dependence field is transforming into a high-growth market opportunity. Supported by the success of Pfizer's recently launched Chantix/Champix, which is on track for blockbuster status in the smoking cessation sector, pharmacotherapies in development for alcohol, narcotic, and nicotine dependencies are poised to radically change the addiction treatment landscape in this difficult-to-treat patient population.The report estimates that the current market for addiction disorders is valued at US$3.2 billion and this is forecast to increase 19% to US$3.8 billion by 2016.The World Market for Addiction Disorders, 2009 2016: Future Therapies for Substance Dependence and Impulse Control, will introduce the reader a specialty pharmaceutical market which is positioned for high-growth based on analysis of marketed and pipeline drugs, company activities, and addiction disorder demographics.Therapy area forecasting and illustrative comparative sales data is presented to gain insight into leading products with sales estimates to 2016.Objectives of ReportThe objectives of this 80 page report are to provide an in-depth analysis of the global addiction pharmacotherapeutic market. Included in this study are analyses of key therapy areas, R&D programs, and innovating companies and products. The reader will benefit from market forecasts, pooled knowledge of recent industrial activities and events, and from analytical discourse, which is intended to stimulate growth and create new market opportunities.Report Highlights Include:' The current market for addiction disorders is valued at US$3.2 billion, up from US$2 billion in 2005' Critical analysis of alcohol, cocaine, opiate, and nicotine addictions' Review of epidemiological, aetiological, and demographic data for addiction disorders' Analysis of over 10 key marketed products and inclusion of 34 R&D candidates identified in preclinical to clinical stages of development for addiction disorders' Sales estimates (US$) to 2012 for major therapy areas' Strategic insights for life-cycle optimization and product development' Critical evaluation of leading addiction pharmacotherapies' Emerging markets identified and sector analysis' Trend analysis of industry events and activities over past 2 years' Detailed R&D themes and clusters by addiction area' Data generation on sector and market values between 2004 and 2012 and therapy forecasts by 2020 (US$)' High revenue-yielding prospects identified with projected sales estimations' R&D pipeline positioning for novel candidates' Market insights for product development and drug promotionWhat you can learn from this report:' Which addiction therapies are the current and potential future market leaders' How companies are reformulating products for addiction indications' Which premarket addiction pharmacotherapies are identified as high-value products' Which companies are developing drugs for addiction disorders' Sales predictions to 2016 for addiction pharmacotherapies' What the likely impact of pipeline products will be on value growth of the addiction market over the 10 years' Which addiction subsectors could be niche market opportunities' What the future outlook holds for addiction pharmacotherapies' Insight into R&D trends for alcohol, cocaine, opiate, and nicotine addictions' Which molecules and compounds are main R&D clusters for dependency disorders' Which of the pipeline candidates are top prospects in the addiction market over the next decade and to 2025Report Contains:' Detailed survey and analysis of the current and future global addiction disorder market' Comprehensive update on key marketed products indicated for alcohol, narcotic, and nicotine dependency disorders' Review of epidemiological, demographic, aetiological, and therapeutic data associated with addiction disorders' Market analysis and insight of key

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
World Market for Addiction Disorders, 2009 - 2016: The Future
Therapies for Substance Dependence and Impulse Control
Published on October 2009
Report Summary
A comprehensive update of the 2005 edition
Examines the market for addiction pharmacotherapies currently estimated at US$2 billion
The substance dependence field is transforming into a high-growth market opportunity. Supported by the success of Pfizer's recently
launched Chantix/Champix, which is on track for blockbuster status in the smoking cessation sector, pharmacotherapies in
development for alcohol, narcotic, and nicotine dependencies are poised to radically change the addiction treatment landscape in this
difficult-to-treat patient population.
The report estimates that the current market for addiction disorders is valued at US$3.2 billion and this is forecast to increase 19% to
US$3.8 billion by 2016.
The World Market for Addiction Disorders, 2009 2016: Future Therapies for Substance Dependence and Impulse Control, will
introduce the reader a specialty pharmaceutical market which is positioned for high-growth based on analysis of marketed and
pipeline drugs, company activities, and addiction disorder demographics.
Therapy area forecasting and illustrative comparative sales data is presented to gain insight into leading products with sales
estimates to 2016.
Objectives of Report
The objectives of this 80 page report are to provide an in-depth analysis of the global addiction pharmacotherapeutic market. Included
in this study are analyses of key therapy areas, R&D programs, and innovating companies and products. The reader will benefit from
market forecasts, pooled knowledge of recent industrial activities and events, and from analytical discourse, which is intended to
stimulate growth and create new market opportunities.
Report Highlights Include:
'The current market for addiction disorders is valued at US$3.2 billion, up from US$2 billion in 2005
'Critical analysis of alcohol, cocaine, opiate, and nicotine addictions
'Review of epidemiological, aetiological, and demographic data for addiction disorders
'Analysis of over 10 key marketed products and inclusion of 34 R&D candidates identified in preclinical to clinical stages of
development for addiction disorders
'Sales estimates (US$) to 2012 for major therapy areas
'Strategic insights for life-cycle optimization and product development
'Critical evaluation of leading addiction pharmacotherapies
'Emerging markets identified and sector analysis
'Trend analysis of industry events and activities over past 2 years
'Detailed R&D themes and clusters by addiction area
'Data generation on sector and market values between 2004 and 2012 and therapy forecasts by 2020 (US$)
'High revenue-yielding prospects identified with projected sales estimations
'R&D pipeline positioning for novel candidates
'Market insights for product development and drug promotion
World Market for Addiction Disorders, 2009 - 2016: The Future Therapies for Substance Dependence and Impulse Control Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
What you can learn from this report:
'Which addiction therapies are the current and potential future market leaders
'How companies are reformulating products for addiction indications
'Which premarket addiction pharmacotherapies are identified as high-value products
'Which companies are developing drugs for addiction disorders
'Sales predictions to 2016 for addiction pharmacotherapies
'What the likely impact of pipeline products will be on value growth of the addiction market over the 10 years
'Which addiction subsectors could be niche market opportunities
'What the future outlook holds for addiction pharmacotherapies
'Insight into R&D trends for alcohol, cocaine, opiate, and nicotine addictions
'Which molecules and compounds are main R&D clusters for dependency disorders
'Which of the pipeline candidates are top prospects in the addiction market over the next decade and to 2025
Report Contains:
'Detailed survey and analysis of the current and future global addiction disorder market
'Comprehensive update on key marketed products indicated for alcohol, narcotic, and nicotine dependency disorders
'Review of epidemiological, demographic, aetiological, and therapeutic data associated with addiction disorders
'Market analysis and insight of key addiction pharmacotherapies and pipelines
'Market value predictions of individual marketed products to 2016
'Insight and trend analysis of pipeline products for addiction disorders
'Review of promising pipeline products and potential market opportunities
'Extensive coverage of the R&D pipeline for addiction disorders
'Guide to leads for potential licensing opportunities
Companies Mentioned in this Report include
Acrux Alkermes Biotie Therapies Brookwood Pharmaceuticals Catalyst Pharma Partners Celtic Pharmaceuticals Cephalon
Drug Abuse Sciences Elbion Eli Lilly Forest Laboratories GlaxoSmithKline Impax Laboratories InterveXion Therapeutics J&J
Janssen-Cilag Krele Pharma Merck Serono Nabi Biopharmaceuticals Pfizer Sanofi-Aventis Somaxon Pharma. STADA
Synosia Therapeutics Targacept Teva Pharmaceuticals Titan Pharmaceuticals WorldMeds Yaupon Therapeutics
Table of Content
Chapter 1. Introduction to Addiction Disorders Addiction: Substance Characteristics and Prevalence of Misuse Neurobiological Basis
of Addiction Prevalence of Substance Misuse - Estimates for North America, Europe and Asia North America United States Canada
Europe Asia (Japan) Incidence Estimates for Addiction Disorders in North America, Europe, and Japan Treatment Options
Chapter 2. The Addiction Pharmacotherapy Market Market Overview for Addiction Disorders Market Forecasts by Therapeutic Area
Alcohol Addiction Narcotic Addiction Tobacco Addiction Chapter 3. Alcohol Addiction Market Alcohol Addiction Acamprosate
(Campral) - Merck Serono/Forest Laboratories Disulfiram (Antabuse) - Alpharma Naltrexone Hydrochloride Alkermes - Reformulated
Naltrexone (Vivitrol) Pipeline Focus for Alcohol Addiction - Biotie Therapies Corp Nalmefene Naltrexone Depot Alcohol Addiction
- Market Insights and Future Considerations Chapter 4. The Narcotic Addiction Market Global Narcotics - Usage Statistics Narcotic
Addiction - The Scale of the Problem Pharmacotherapies for Narcotic Addiction - Market Evaluation Opioid Addiction
Pharmacotherapies Drug Substitute Therapies Subutex/Suboxone (Buprenorphine) - Schering-Plough/Reckitt Benckiser Suboxone
Reformulation Methadone Drugs to Control Opioid Withdrawal Symptoms BritLofex (Lofexidine); Opizone (Naltrexone) - Britannia
Pharma/STADA Naltrexone Nalorex - Bristol-Myers Squibb Opizone - Britannia Therapeutic Switching in Addiction Markets Outlook
for Pharmacotherapeutic Markets Related to Alcohol and Narcotic Abuse Chapter 5. Tobacco Addiction Prevalence and Mortality
Statistics Nicotine: Mechanism of Action Tobacco Dependence and Smoking Cessation Smoking and Health Consequences
World Market for Addiction Disorders, 2009 - 2016: The Future Therapies for Substance Dependence and Impulse Control Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Healthcare Costs of Smoking Addiction Tobacco Addiction Pharmacotherapeutics Market Analysis of Smoking Cessation
Pharmacotherapeutics Nicotine Replacement Therapies Nicorette/Nicotrol - McNeil Healthcare/Johnson & Johnson Sales Estimates
NiQuitin/NicoDerm/Nicorette/Nicabate - GlaxoSmithKline Sales Estimates Nicotinell/Habitrol - Novartis Sales Estimates
Neuromodulating Pharmacotherapies for Smoking Cessation Zyban (Bupropion) - GlaxoSmithKline Sales Estimates Champix/Chantix
(Varenicline) - Pfizer Sales Estimates Tobacco Addiction - Market Insights and Future Considerations Chapter 6. Drugs in
Research and Development Addiction Disorders - Research and Development Overview Pipeline Addiction Pharmacotherapies
Alcohol Dependence Cocaine Dependence Novel Late-Stage Candidates Celtic Pharmaceuticals Synosia Therapeutics/Roche
Cannabis Dependence Immunotherapy Focus - InterveXion Therapeutics Opioid Dependence Late-Stage Development Products
for Opioid Dependence Impulse Control Disorders Pipeline Focus - Gambling Addiction Tobacco/Nicotine Dependence Pipeline
Focus on Immunotherapies for Tobacco Dependence Nabi Biopharmaceuticals - NicVAX Celtic Pharmaceuticals - TA-NIC
Smoking Cessation - A Transforming Market Chapter 7. Market Analysis, Therapy Forecasting, and Prospect Mining Market
Analysis and Therapy Forecasting Therapy Area Forecasts Comparative Analysis: Addiction Pharmacotherapies Prospect Mining
Addiction Disorder Pharmacotherapy Prospects Therapy Area Forecasts 2016 and 2025 Chapter 8. Summary and Key Data
Points on the Addiction Market Key Data Points Reference Sources List of Tables Table 1.1 Neurotransmitter Systems Associated
with Addiction Table 1.2 Drugs of Abuse and their Associations with Neurotransmitter Systems Table 1.3 Estimated Prevalence of
Substance Misuse in Europe, 2009 (000' users) Table 1.4 Estimated Incidence for Addiction Disorders in North America, Europe and
Japan, 2009 (incidence in 000s) Table 2.1 Market Synopsis for Addiction Disorders: Current data Table 2.2 Estimated Global Sales
(US$) and Annual Growth (%) of Key Drugs to Treat Addictions, 2008-2016 Table 3.1 Physiological Consequences of the
Disulfiram-Alcohol Reaction Table 5.1 Estimated Sales (US$) and Annual Growth (%) of Smoking Cessation Therapies, 2008-2016
Table 6.1 Drugs in Development/Trials for Alcohol Dependence, 2009 Table 6.2 Drugs in Development/Trials for Cocaine
Dependence, 2009 Table 6.3 Drugs in Development/Trials for Cannabis Dependence, 2009 Table 6.4 Drugs in Development/Trials
for Ampetamine and Phencyclidine Dependencies, 2009 Table 6.5 Drugs in Development/Trials for Opioid Dependence, 2009 Table
6.6 Drugs in Development/Trials for Impulse Control Disorders, 2009 Table 6.7 Drugs in Development/Trials for Tobacco Addiction,
2009 Table 7.1 Estimated Global Drug Market (US$m) and Growth Rate (%) for Addiction Pharmacotherapies, 2008-2016 Table 7.2
Therapy Area Forecasts for the World Addiction Disorders Market, 2016 and 2025 List of Figures Figure 1.1 Estimated Prevalence
of Substance Misuse in United States, 2009 Figure 1.2 stimated Prevalence of Substance Misuse in Canada, 2009 Figure 1.3
Estimated Prevalence of Substance Misuse in Europe, 2009 Figure 1.4 Estimated Prevalence of Substance Misuse in Japan, 2009
Figure 2.1 Estimated Sales (US$) of Addiction Drugs Segmented by Therapeutic Area, 2008-2016 Figure 2.2 Estimated Global Sales
(US$) of Leading Addiction Drugs by Therapy Area, 2009 & 2016 Figure 7.1 Comparative Analysis of Leading Addiction
Pharmacotherapies, 2008-2016 (US$m) Figure 7.2 Key Addiction Disorder Pharmacotherapy Prospects, 2009
World Market for Addiction Disorders, 2009 - 2016: The Future Therapies for Substance Dependence and Impulse Control Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
World Market for Addiction Disorders, 2009 - 2016: The Future Therapies for Substance Dependence and Impulse
Control
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 2 149.06 Quantity: _____
Corporate License--USD 12 439.61 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
World Market for Addiction Disorders, 2009 - 2016: The Future Therapies for Substance Dependence and Impulse Control Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
World Market for Addiction Disorders, 2009 - 2016: The Future Therapies for Substance Dependence and Impulse Control Page 5/5